Molecular Human Reproduction, Vol. 6, No. 7, 635-641,
July 2000
© 2000 European Society of Human Reproduction and Embryology
Pregnancy |
Cytotoxic effects of tumour necrosis factor (TNF)-
and interferon-
on cultured human trophoblast are modulated by fibronectin
1 Department of Obstetrics & Gynaecology, University Hospital Gasthuisberg, Katholieke Universiteit Leuven,B3000 Leuven, Belgium, and 2 Genetics Institute Inc., Cambridge Mass., USA
Abstract
Tumour necrosis factor (TNF)-
and interferon (IFN)-
, produced by maternal inflammatory cells, may compromise trophoblast survival at the trophoblast–maternal interface and notably in the placental bed which is invaded by trophoblast. Extracellular matrix components, e.g. fibronectin, may enhance trophoblast survival. A possible protective effect of fibronectin against toxic effects of TNF- and IFN- was investigated in cultured trophoblasts isolated from six human term placentas, grown on uncoated and fibronectin-coated plastics. IFN- and increasing doses of TNF- resulted in decreasing viability of trophoblast on uncoated as well as fibronectin-coated dishes, as shown by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assays, but for each TNF/IFN treatment condition viability on fibronectin was higher (P < 0.001). Epidermal growth factor (EGF), a growth factor reported to protect against TNF-/IFN- induced toxicity, resulted in further increased viability, but not if IFN- was included in the treatment. EGF caused increased fibronectin secretion into the medium (P < 0.001), and double cytokeratin/fibronectin immunostaining confirmed the trophoblastic nature of fibronectin secreting cells. We conclude that fibronectin increases viability, but does not completely abolish the cytotoxic action of TNF- and IFN- on trophoblast. The protective effect of EGF may be related to stimulation of fibronectin secretion by trophoblast.
epidermal growth factor/fibronectin /interferon-/trophoblast/tumour necrosis factor-
Notes
3 To whom correspondence should be addressed at: Department of Obstetrics & Gynaecology, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, B3000 Leuven, Belgium. E-mail: robert.pijnenborg{at}uz.kuleuven.ac.be
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Al-Nasiry, N. Geusens, M. Hanssens, C. Luyten, and R. Pijnenborg The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells Hum. Reprod., May 1, 2007; 22(5): 1304 - 1309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Lash, H. A. Otun, B. A. Innes, M. Kirkley, L. De Oliveira, R. F. Searle, S. C. Robson, and J. N. Bulmer Interferon-{gamma} inhibits extravillous trophoblast cell invasion by a mechanism that involves both changes in apoptosis and protease levels FASEB J, December 1, 2006; 20(14): 2512 - 2518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Debrock, B. De Strooper, S. V. Perre, J. A. Hill, and T. M D'Hooghe Tumour necrosis factor-{alpha}, interleukin-6 and interleukin-8 do not promote adhesion of human endometrial epithelial cells to mesothelial cells in a quantitative in vitro model Hum. Reprod., March 1, 2006; 21(3): 605 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Al-Nasiry, B. Spitz, M. Hanssens, C. Luyten, and R. Pijnenborg Differential effects of inducers of syncytialization and apoptosis on BeWo and JEG-3 choriocarcinoma cells Hum. Reprod., January 1, 2006; 21(1): 193 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-H. Baek Aberrant gene expression associated with recurrent pregnancy loss Mol. Hum. Reprod., May 1, 2004; 10(5): 291 - 297. [Abstract] [Full Text] [PDF]
|
|